AI assistant
Sending…
PRECIGEN, INC. — Director's Dealing 2021
Oct 20, 2021
32044_dirs_2021-10-20_eeaa5cab-7db0-4c46-99db-ff6826df2039.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2021-10-18
Reporting Person: Thomasian Harry Jr. (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-10-18 | Option to Purchase Common Stock (Right to Buy) | $4.72 | A | 180000 | Acquired | 2031-10-18 | Common Stock (180000) | Direct |
Footnotes
F1: The option vests in four equal installments on each of October 18, 2022, October 18, 2023, October 18, 2024 and October 18, 2025.
More from PRECIGEN, INC.
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Jan 23
Director's Dealing
2025
Dec 23